加科思-B(01167)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01167 加科思-B

已收盘 12-05 16:09:08

8.240

+0.090

+1.10%

最高8.290	最低8.010	成交量252.17万
今开8.110	昨收8.150	日振幅3.44%
总市值64.85亿	流通市值64.85亿	总股本7.87亿
成交额2,061万	换手率0.32%	流通股本7.87亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01167","market":"HK","secType":"STK","nameCN":"加科思-B","latestPrice":8.24,"timestamp":1764922148002,"preClose":8.15,"halted":0,"volume":2521744,"delay":0,"floatShares":787000000,"shares":787000000,"eps":-0.22132135969856442,"marketStatus":"已收盘","change":0.09,"latestTime":"12-05 16:09:08","open":8.11,"high":8.29,"low":8.01,"amount":20612433,"amplitude":0.034356,"askPrice":8.25,"askSize":2100,"bidPrice":8.24,"bidSize":3600,"shortable":3,"etf":0,"ttmEps":-0.06499203201195776,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":5,"adr":0,"listingDate":1608480000000,"exchange":"SEHK","adjPreClose":8.15,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":0.831047,"lotSize":300,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01167","defaultTab":"news","newsList":[{"id":"2588077315","title":"加科思-B午前涨超6% 附属收到海松资本支付的1.25亿元首付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2588077315","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588077315?lang=zh_cn&edition=full","pubTime":"2025-12-04 11:31","pubTimestamp":1764819111,"startTime":"0","endTime":"0","summary":"加科思-B午前股价上涨6.17%，现报8.09港元，成交额1765.87万港元。公司附属公司北京加科思，就其订立的增资协议及股权转让协议，已收到海松资本支付的人民币1.25亿元的首付款。此外，加科思近日宣布，公司自研的KRAS G12C抑制剂戈来雷塞联合SHP2抑制剂JAB-3312的临床I/IIa期研究成果正式发表于国际顶级医学期刊《柳叶刀呼吸医学》。这是全球首次有KRAS G12C与SHP2双口服小分子联合疗法的系统性临床资料登上该权威期刊。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2025/12/04113154566651.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","BK1574","01167"],"gpt_icon":0},{"id":"2588207146","title":"港股异动 | 加科思-B(01167)盘中涨超6% 附属收到1.25亿元首付款 联合疗法登上《柳叶刀》","url":"https://stock-news.laohu8.com/highlight/detail?id=2588207146","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588207146?lang=zh_cn&edition=full","pubTime":"2025-12-04 10:29","pubTimestamp":1764815363,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，加科思-B盘中涨超6%，截至发稿，涨5.51%，报8.04港元，成交额815.25万港元。消息面上，加科思发布公告，公司的附属公司北京加科思已收到海松资本支付的人民币1.25亿元的首付款。此外，加科思近日宣布，公司自研的KRAS G12C抑制剂戈来雷塞联合SHP2抑制剂JAB-3312的临床I/IIa期研究成果正式发表于国际顶级医学期刊《柳叶刀呼吸医学》。这是全球首次有KRAS G12C与SHP2双口服小分子联合疗法的系统性临床资料登上该权威期刊。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377587.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01167","BK1574","BK1161"],"gpt_icon":0},{"id":"1169849656","title":"加科思药业（01167）更新2025年11月股份变动月报表，累计购回481,200股","url":"https://stock-news.laohu8.com/highlight/detail?id=1169849656","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169849656?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:57","pubTimestamp":1764752263,"startTime":"0","endTime":"0","summary":"加科思药业集团有限公司于2025年12月3日更新发布截至2025年11月30日的股份变动月报表。公告显示，公司本月无注册股本变化，注册股本维持在10亿美元，折合10万美元。公司本月累计购回481,200股，购回价格区间为6.53港元至7.21港元，暂未注销，列作库存股。公告同时披露，本月未有股份期权、权证或可换股债等其他股权激励或转换安排的变动。公司确认截至2025年11月末，其股本总数保持稳定。公告由董事王晓洁签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"gpt_icon":0},{"id":"2588074934","title":"每日卖空追踪 | 加科思-B 12月03日卖空量成交40.68万股，卖空比例为14.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588074934","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588074934?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:30","pubTimestamp":1764750617,"startTime":"0","endTime":"0","summary":"加科思-B北京时间12月03日，跌1.68%，卖空量成交40.68万股，较上一交易日减少44.47%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163238978d7a94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163238978d7a94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01167","BK1161"],"gpt_icon":0},{"id":"2588097646","title":"加科思-B12月02日主力净流出31.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2588097646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588097646?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:15","pubTimestamp":1764663336,"startTime":"0","endTime":"0","summary":"12月02日, 加科思-B股价跌0.26%，报收7.75元，成交金额2412.8万元，换手率0.39%，振幅3.73%，量比0.62。加科思-B今日主力资金净流出31.6万元，上一交易日主力净流入23.0万元。该股近5个交易日上涨11.34%，主力资金累计净流入550.3万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1846.1万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202161813a71eb4d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202161813a71eb4d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","01167"],"gpt_icon":0},{"id":"2588082138","title":"加科思-B附属公司获海松资本1.25亿元首付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2588082138","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588082138?lang=zh_cn&edition=full","pubTime":"2025-12-02 14:50","pubTimestamp":1764658201,"startTime":"0","endTime":"0","summary":"12月2日，加科思-B（01167）发布公告，公司的附属公司北京加科思已收到海松资本支付的1.25亿元的首付款，涉及增资协议及股权转让协议。这笔首付款的到账将进一步充盈公司的现金储备，并为后续创新肿瘤疗法管线研发提供支持。此次交易的背景是公司与北京加科瑞康医药科技有限公司、山西海松管理咨询合伙企业及产业合作方于2025年10月15日签署的增资协议及股权转让协议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512023580288786.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK1161","01167"],"gpt_icon":0},{"id":"2588089500","title":"加科思-B(01167)收到增资协议及股权转让协议项下的首付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2588089500","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588089500?lang=zh_cn&edition=full","pubTime":"2025-12-02 12:43","pubTimestamp":1764650631,"startTime":"0","endTime":"0","summary":"智通财经APP讯，加科思-B(01167)发布公告，内容有关北京加科思、加科瑞康、海松资本及一名产业合作方订立的增资协议及股权转让协议。公司董事会欣然宣布，公司的附属公司北京加科思(公司间接非全资附属公司)，就其订立的增资协议及股权转让协议，已收到海松资本支付的人民币1.25亿元的首付款。该首付款的到账，进一步充盈了集团的现金储备，也将为集团后续创新肿瘤疗法管线研发的推进提供助力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376422.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","01167"],"gpt_icon":0},{"id":"2588706718","title":"每日卖空追踪 | 加科思-B 12月01日卖空量成交19.17万股，卖空比例为7.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588706718","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588706718?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:30","pubTimestamp":1764577819,"startTime":"0","endTime":"0","summary":"加科思-B北京时间12月01日，跌2.51%，卖空量成交19.17万股，较上一交易日减少60.24%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163220a71c7056&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163220a71c7056&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","01167"],"gpt_icon":0},{"id":"2588716292","title":"加科思-B(01167)：加科思KRAS G12C与SHP2联合疗法数据见刊《柳叶刀呼吸医学》","url":"https://stock-news.laohu8.com/highlight/detail?id=2588716292","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588716292?lang=zh_cn&edition=full","pubTime":"2025-12-01 07:47","pubTimestamp":1764546428,"startTime":"0","endTime":"0","summary":"智通财经APP讯，加科思-B 发布公告，公司自研的KRAS G12C抑制剂戈来雷塞联合SHP2抑制剂JAB-3312的临床I/IIa期研究成果正式发表于国际顶级医学期刊《柳叶刀呼吸医学》。这是全球首次有KRAS G12C与SHP2双口服小分子联合疗法的系统性临床资料登上该权威期刊。目前，KRAS G12C抑制剂与SHP2抑制剂正在中国开展三期临床试验，将在一线患者中直接对比该联合方案与现行标准治疗路径，推动该双口服组合成为全球首个有望获批的SHP2联合治疗方案。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375715.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"加科思-B(01167)：加科思KRAS G12C与SHP2联合疗法数据见刊《柳叶刀呼吸医学》","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["01167","BK1574","BK1161"],"gpt_icon":1},{"id":"2586404272","title":"每日卖空追踪 | 加科思-B 11月27日卖空量成交10.47万股，卖空比例为1.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586404272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586404272?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:30","pubTimestamp":1764232217,"startTime":"0","endTime":"0","summary":"加科思-B北京时间11月27日，涨6.27%，卖空量成交10.47万股，较上一交易日减少82.65%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511271635029782633d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511271635029782633d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","01167"],"gpt_icon":0},{"id":"2586272267","title":"加科思-B11月27日主力净流入619.9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2586272267","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586272267?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:15","pubTimestamp":1764231351,"startTime":"0","endTime":"0","summary":"11月27日, 加科思-B股价涨6.27%，报收7.97元，成交金额5277.4万元，换手率0.84%，振幅12.93%，量比0.63。加科思-B今日主力资金净流入619.9万元，上一交易日主力净流出100.2万元。该股近5个交易日上涨0.50%，主力资金累计净流入586.5万元；近20日主力资金累计净流入1713.0万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112716204697825c3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112716204697825c3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","01167"],"gpt_icon":0},{"id":"2586347203","title":"每日卖空追踪 | 加科思-B 11月25日卖空量成交62.46万股，卖空比例为8.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586347203","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586347203?lang=zh_cn&edition=full","pubTime":"2025-11-25 16:30","pubTimestamp":1764059418,"startTime":"0","endTime":"0","summary":"加科思-B北京时间11月25日，涨2%，卖空量成交62.46万股，较上一交易日增加0.97%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125163230a4b8fc92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125163230a4b8fc92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","01167"],"gpt_icon":0},{"id":"2586747272","title":"加科思-B盘中异动 股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586747272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586747272?lang=zh_cn&edition=full","pubTime":"2025-11-25 10:12","pubTimestamp":1764036723,"startTime":"0","endTime":"0","summary":"2025年11月25日早盘10时12分，加科思-B股票出现波动，股价急速拉升5.14%。截至发稿，该股报7.360港元/股，成交量124.92万股，换手率0.16%，振幅4.71%。资金方面，该股资金流入456.884万港元，流出407.218万港元。加科思-B股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，银诺医药-B、乐普生物-B、加科思-B涨幅较大，振幅较大的相关个股有华康生物医学、科笛-B、银诺医药-B，振幅分别为16.90%、14.42%、9.48%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125101203a70f7355&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125101203a70f7355&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","01167"],"gpt_icon":0},{"id":"2585730123","title":"每日卖空追踪 | 加科思-B 11月21日卖空量成交96.69万股，卖空比例为7.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585730123","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585730123?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:30","pubTimestamp":1763713820,"startTime":"0","endTime":"0","summary":"加科思-B北京时间11月21日，跌11.98%，卖空量成交96.69万股，较上一交易日减少47.08%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112116332095124eb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112116332095124eb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","01167"],"gpt_icon":0},{"id":"2585237321","title":"加科思-B盘中异动 早盘急速下挫5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585237321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585237321?lang=zh_cn&edition=full","pubTime":"2025-11-21 09:30","pubTimestamp":1763688633,"startTime":"0","endTime":"0","summary":"2025年11月21日早盘09时30分，加科思-B股票出现异动，股价快速跳水5.30%。截至发稿，该股报7.510港元/股，成交量16.38万股，换手率0.02%，振幅4.29%。加科思-B股票所在的生物技术行业中，整体跌幅为1.87%。其相关个股中，华康生物医学、中生北控生物科技、永泰生物-B涨幅较大，振幅较大的相关个股有加科思-B、复宏汉霖、三叶草生物-B，振幅分别为4.29%、3.62%、3.05%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112109303397769481&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112109303397769481&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01167","BK1161"],"gpt_icon":0},{"id":"2584133113","title":"每日卖空追踪 | 加科思-B 11月20日卖空量成交30.15万股，卖空比例为1.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584133113","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584133113?lang=zh_cn&edition=full","pubTime":"2025-11-20 16:30","pubTimestamp":1763627419,"startTime":"0","endTime":"0","summary":"加科思-B北京时间11月20日，涨19.97%，卖空量成交30.15万股，较上一交易日增加270.85%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511201634229775368c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511201634229775368c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01167","BK1574"],"gpt_icon":0},{"id":"2584334361","title":"加科思-B午前涨逾6% 自研KRAS G12C抑制剂戈来雷塞获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2584334361","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584334361?lang=zh_cn&edition=full","pubTime":"2025-11-20 11:45","pubTimestamp":1763610325,"startTime":"0","endTime":"0","summary":"平安证券发布研报称，加科思-B自研KRAS G12C抑制剂戈来雷塞获批上市，就国内商业化已与艾力斯达成授权合作，同步多项注册临床进行中以最大化资产临床及市场价值。KRAS对细胞生长、分化、增殖等起到重要作用，是癌症发生突变的主要基因，对此除已上市戈来雷塞外，加科思-B布局泛KRAS抑制剂JAB-23E73 和KRAS G12D旨在覆盖KRAS不同突变亚型及深入克服耐药问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120114924a705c510&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120114924a705c510&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","01167"],"gpt_icon":0},{"id":"2584490657","title":"港股异动 | 加科思-B(01167)涨超5% 泛KRAS抑制剂JAB-23E73有望于明年上半年披露1期爬坡数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2584490657","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584490657?lang=zh_cn&edition=full","pubTime":"2025-11-20 10:46","pubTimestamp":1763606776,"startTime":"0","endTime":"0","summary":"值得关注的是，泛KRAS抑制剂JAB-23E73预计2026上半年披露1期爬坡数据，创新型靶向EGFR KRAS G12D tADC预计2026年递交IND申请，先发搭建专利组合有望进一步形成竞争壁垒。KRAS对细胞生长、分化、增殖等起到重要作用，是癌症发生突变的主要基因，对此除已上市戈来雷塞外，加科思-B布局泛KRAS抑制剂JAB-23E73 和KRAS G12D旨在覆盖KRAS不同突变亚型及深入克服耐药问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1371408.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","01167"],"gpt_icon":0},{"id":"1137449577","title":"加科思-B宣布任命Andrea Wang-Gillam为联席首席执行官","url":"https://stock-news.laohu8.com/highlight/detail?id=1137449577","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137449577?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:34","pubTimestamp":1763573653,"startTime":"0","endTime":"0","summary":"11月13日——加科思-B（Jacobio Pharmaceuticals Group Co Ltd <1167.HK>）宣布任命Andrea Wang-Gillam为联席首席执行官。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","01167","BK1161"],"gpt_icon":0},{"id":"2584973301","title":"每日卖空追踪 | 加科思-B 11月19日卖空量成交4.5万股，卖空比例为1.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584973301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584973301?lang=zh_cn&edition=full","pubTime":"2025-11-19 16:30","pubTimestamp":1763541017,"startTime":"0","endTime":"0","summary":"加科思-B北京时间11月19日，跌0.3%，卖空量成交4.5万股，较上一交易日减少65.68%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511191632299772fcb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511191632299772fcb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","01167"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jacobiopharma.com","stockEarnings":[{"period":"1week","weight":0.0226},{"period":"1month","weight":0.1744},{"period":"3month","weight":-0.2857},{"period":"6month","weight":0.5949},{"period":"1year","weight":4.5822},{"period":"ytd","weight":5.4173}],"compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":-0.0006},{"period":"3month","weight":0.0204},{"period":"6month","weight":0.0901},{"period":"1year","weight":0.3137},{"period":"ytd","weight":0.2929}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"加科思药业集团有限公司是一家主要从事临床阶段新药研发的投资控股公司。该公司主要负责创新肿瘤疗法的自主发现和开发。该公司主要药物开发项目包括JAB-21822及JAB-3312临床阶段的变构SHP2抑制剂。该公司主要在中国市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.019197},{"month":2,"riseRate":0.4,"avgChangeRate":0.181109},{"month":3,"riseRate":0.2,"avgChangeRate":-0.02925},{"month":4,"riseRate":0.6,"avgChangeRate":0.038742},{"month":5,"riseRate":0.4,"avgChangeRate":0.066021},{"month":6,"riseRate":0,"avgChangeRate":-0.081428},{"month":7,"riseRate":0.4,"avgChangeRate":0.073857},{"month":8,"riseRate":0.2,"avgChangeRate":0.005746},{"month":9,"riseRate":0.6,"avgChangeRate":-0.002238},{"month":10,"riseRate":0.2,"avgChangeRate":-0.065405},{"month":11,"riseRate":0.4,"avgChangeRate":0.020921},{"month":12,"riseRate":0.4,"avgChangeRate":-0.023573}],"exchange":"SEHK","name":"加科思-B","nameEN":"JACOBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"加科思-B(01167)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供加科思-B(01167)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"加科思-B,01167,加科思-B股票,加科思-B股票老虎,加科思-B股票老虎国际,加科思-B行情,加科思-B股票行情,加科思-B股价,加科思-B股市,加科思-B股票价格,加科思-B股票交易,加科思-B股票购买,加科思-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"加科思-B(01167)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供加科思-B(01167)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}